Fetal And Neonatal Care Equipment Market Size and Share

Fetal and Neonatal Care Equipment Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Fetal And Neonatal Care Equipment Market Analysis by Mordor Intelligence

The fetal and neonatal care equipment market was valued at USD 9.68 billion in 2025 and is forecast to reach USD 13.15 billion by 2030, advancing at a 6.31% CAGR. Growth stems from the convergence of higher preterm birth rates, wider use of AI-powered predictive analytics, and sizeable government investments that expand neonatal intensive-care capacity, especially in China where maternal mortality fell to 14.3 per 100,000 in 2024.[1]Global Times, “China’s maternal, infant, and under-5 mortality rates hit historic lows in 2024,” globaltimes.cn Rising demand for wireless and portable monitors is dismantling long-standing reliance on tethered systems, while cybersecurity requirements influence product design and procurement decisions.[2]Food and Drug Administration, “Cybersecurity Vulnerabilities with Certain Patient Monitors,” fda.govHospital buying power remains decisive, yet remote monitoring programs that enable early discharge are shifting revenue toward home-care channels. Competitive dynamics intensify as leading manufacturers integrate AI algorithms, secure-by-design architectures, and cloud connectivity, often through targeted acquisitions of start-ups that specialize in fetal diagnostics.

Key Report Takeaways

  • By product type, neonatal equipment retained 56.23% of the fetal and neonatal care equipment market share in 2024, whereas the fetal care segment is poised to expand at an 8.02% CAGR to 2030.
  • By end user, hospitals held 52.33% of revenue in 2024; home-care settings record the fastest growth at a 10.48% CAGR through 2030.
  • By modality, stand-alone devices accounted for 68.33% of the 2024 fetal and neonatal care equipment market size, yet portable and hand-held systems are growing at 8.75% CAGR.
  • By geography, North America led with 38.69% revenue in 2024, while Asia Pacific is the fastest-growing region at a 9.01% CAGR.

Segment Analysis

By Product Type: Neonatal Equipment Dominance Faces Fetal Innovation Surge

Neonatal equipment controlled 56.23% of 2024 revenue in the fetal and neonatal care equipment market, anchored by incubators, ventilators, and thermoregulation systems sold into expanding NICU footprints. Incubators led unit shipments, with enhancements such as humidity-regulated micro-environments and integrated jaundice forecasting software like Draeger’s BiliPredics elevating clinical value. Respiratory support devices capitalized on rising very-preterm survival rates; Vyaire’s fabian Therapy evolution now offers closed-loop FiO₂ control that reduces manual titration time. The fetal and neonatal care equipment market size for neonatal respiratory devices is projected to climb at 7.2% CAGR through 2030 as guidelines favor early non-invasive ventilation.

Fetal care devices, though smaller in absolute revenue, are on track for an 8.02% CAGR. AI-enhanced ultrasound, exemplified by GE’s Vscan Air CL and Exo’s Iris handheld with SweepAI algorithms, shortens exam times while improving detection fidelity. NIH funding that awarded USD 75,000 to six RADx finalists validates pipeline momentum in non-invasive pulse-oximetry and wearable cardiotocography solutions. The fetal and neonatal care equipment market size for pulse oximeters is forecast to expand 9.4% annually, reflecting demand for continuous, cable-free oxygen-saturation tracking during labor and the early neonatal period.

Market Segment Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End-User: Hospital Infrastructure Expansion Contrasts Home-Care Acceleration

Hospitals represented 52.33% of 2024 earnings within the fetal and neonatal care equipment market, sustained by bond-financed expansions such as the USD 204 million Packard Children’s project that added 149 specialty beds. Integrated workstation procurement that bundles monitors, phototherapy, and ventilators into a single capital outlay optimizes staff workflow and appeals to finance committees striving for return on investment. Emergency departments increasingly specify hand-carried ultrasound for rapid neonatal triage, reinforcing core demand.

Home-care deployments, while niche in volume, grow at a 10.48% CAGR. Masimo SafetyNet couples disposable pulse--ox sensors with cloud dashboards, enabling earlier discharge of premature newborns without compromising safety. Nuvo’s INVU platform, now publicly listed, offers FDA-cleared remote non-stress testing for pregnant women unable to reach clinics regularly nuvocares.com. These initiatives align with payer objectives to cut length of stay, expanding revenue for portable equipment vendors inside the fetal and neonatal care equipment market.

Market Segment share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Modality: Wireless Revolution Challenges Stand-Alone Supremacy

Stand-alone units still commanded 68.33% of 2024 sales, yet the market tilts steadily toward portable systems. Hospitals value the reliability and familiar integration workflows of large-footprint incubators and monitors that tie into legacy patient-record systems. High-end stand-alone equipment now embeds IoT gateways and AI analytics that deliver predictive maintenance alerts, blurring the line between classic consoles and connected solutions.

Portable and hand-held devices expand at an 8.75% CAGR, boosted by GE’s Novii+ patch that captures maternal and fetal heart rates wirelessly from 34 weeks gestation. Philips’ FDA-cleared Remote Fetal Monitoring band enables at-home non-stress tests, improving patient comfort while decreasing clinic congestion. Contactless radar and camera-based respiration sensors promise adhesive-free monitoring, resonating with infection-control mandates and broadening the fetal and neonatal care equipment market.

Geography Analysis

North America generated 38.69% of global revenue in 2024 on the back of advanced NICU penetration and early AI adoption. Nevertheless, extended FDA timelines and cybersecurity compliance costs temper near-term growth. The fetal and neonatal care equipment market size in North America is set to rise from USD 3.75 billion in 2025 to USD 4.9 billion by 2030 at a 5.5% CAGR.

Asia Pacific charts a 9.01% CAGR, underpinned by Chinese and Indian public-health investments and aggressive technology scale-up programs. Samsung Medison’s USD 93 million purchase of Sonio signals regional ambition to dominate AI-fetal diagnostics. India’s National Health Mission continues to distribute free neonatal care packages that spur equipment demand in secondary-tier cities.

Europe maintains steady mid-single-digit expansion, helped by sustainability procurement rules that favor helium-free MRI and cableless monitors. Latin America focuses on cost-optimized imports, and the Middle East invests via public-private partnerships to upgrade maternal-fetal services.

Geography growth
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

There is moderate consolidation inside the fetal and neonatal care equipment market. GE reported 3% sales growth in Q1 2025, supported by its partnership with Raydiant Oximetry on wireless fetal oximeters. Philips teamed with Mass General Brigham to create AI data ecosystems that integrate bedside devices with predictive dashboards. Medtronic launched the VitalFlow ECMO system, targeting neonatal indications with real-time performance analytics.

Strategic acquisitions accelerate capability gaps: Samsung Medison bought Sonio to secure AI cardiac-assessment algorithms, and BrightHeart secured FDA clearance for its automated ultrasound-view detection software. Cyber-secure design and regulatory IQ now represent core differentiators; vendors able to document Software Bill of Materials and continuous patch strategies gain bid advantages under new FDA rules.

Mid-tier players target emerging-market white spaces with low-cost, IoT-enabled incubators, while start-ups pioneer adhesive-free sensors, wearable phototherapy wraps, and AI-guided nutrition engines. Competitive intensity is set to climb as telemonitoring reimbursement codes mature, widening access to home-care revenue pools within the fetal and neonatal care equipment market

 

Fetal And Neonatal Care Equipment Industry Leaders

  1. Dragerwerk AG & Co. KGaA

  2. Atom Medical Corporation

  3. GE Healthcare

  4. Koninklijke Philips NV

  5. Becton, Dickinson and Company

  6. *Disclaimer: Major Players sorted in no particular order
Fetal and Neonatal Care Equipment Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • May 2025: BrightHeart gained FDA clearance for B-Right Views, an AI tool that automatically detects standard fetal cardiac views in routine second- and third-trimester scans.
  • March 2025: Draeger introduced BiliPredics software, co-developed with NeoPredics, to forecast bilirubin trajectories up to 60 hours in advance for timely phototherapy decisions.
  • November 2024: BrightHeart secured FDA 510(k) clearance for prenatal ultrasound software that automates image capture and labeling.
  • September 2024: Saint-Denis Hospital Center in France deployed Masimo SafetyNet telemonitoring to support early discharge of premature newborns.

Table of Contents for Fetal And Neonatal Care Equipment Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number Of Pre-Term And Low-Birth-Weight Deliveries
    • 4.2.2 Accelerating Demand For Point-Of-Care Fetal Monitoring In Low-Resource Settings
    • 4.2.3 AI-Powered Predictive Analytics Improving Neonatal Outcomes
    • 4.2.4 Government Support To Boost NICU Capacity Expansion
    • 4.2.5 Shift Toward Non-Contact Phototherapy & Warmers To Reduce Infection Risk
    • 4.2.6 Growth Of Single-Use Disposable Consumables In NICU Workflow
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Timelines For Novel Device Approvals
    • 4.3.2 High Upfront Cost Of Advanced Integrated NICU Workstations
    • 4.3.3 Shortage Of Trained Neonatologists & Nurses In Certain Regions
    • 4.3.4 Cyber-Security Risks In Connected Fetal Monitoring Platforms
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technology Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Bargaining Power of Suppliers
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Threat of New Entrants
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size and Growth Forecasts (Value-USD)

  • 5.1 Fetal Dopplers
    • 5.1.1 Fetal Magnetic Resonance Imaging (MRI) Devices
    • 5.1.1.1 Ultrasound Devices
    • 5.1.1.2 Fetal Pulse Oximeters
    • 5.1.1.3 Other Fetal Care Equipment
    • 5.1.2 Neonatal Care Equipment
    • 5.1.2.1 Incubators
    • 5.1.2.2 Neonatal Monitoring Devices
    • 5.1.2.3 Phototherapy Equipment
    • 5.1.2.4 Respiratory Assistance & Monitoring Devices
    • 5.1.2.5 Other Neonatal Care Equipment
  • 5.2 By End-user
    • 5.2.1 Hospitals
    • 5.2.2 Maternity Clinics & Birthing Centers
    • 5.2.3 Home-Care Settings
  • 5.3 By Modality
    • 5.3.1 Stand-alone Devices
    • 5.3.2 Portable/Hand-held Devices
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.3.1 Atom Medical Corp.
    • 6.3.2 Becton, Dickinson & Co.
    • 6.3.3 Drägerwerk AG & Co. KGaA
    • 6.3.4 GE HealthCare Technologies Inc.
    • 6.3.5 Koninklijke Philips N.V.
    • 6.3.6 Masimo Corp.
    • 6.3.7 Medtronic plc
    • 6.3.8 Natus Medical Inc.
    • 6.3.9 Phoenix Medical Systems Pvt Ltd
    • 6.3.10 Vyaire Medical Inc.
    • 6.3.11 Fisher & Paykel Healthcare Ltd
    • 6.3.12 ICU Medical
    • 6.3.13 Nihon Kohden Corp.
    • 6.3.14 Inspiration Healthcare Group plc
    • 6.3.15 Mennen Medical Group
    • 6.3.16 Fanem LTDA
    • 6.3.17 Bispectral Medical
    • 6.3.18 Heinen + Löwenstein GmbH
    • 6.3.19 Utah Medical Products Inc.

7. Market Opportunities and Future Outlook

  • 7.1 White-Space and Unmet-Need Assessment

Research Methodology Framework and Report Scope

Market Definitions and Key Coverage

Our study defines the global fetal and neonatal care equipment market as annual revenue from purpose-built machines that diagnose, monitor, warm, ventilate, or treat fetuses and infants up to 28 days old inside obstetric units and neonatal intensive care units. This includes fetal ultrasound, cardiotocography, MRI, Dopplers, incubators, warmers, phototherapy lamps, respiratory support devices, and integrated vital-sign monitors sold new as stand-alone or portable systems.

Scope exclusion: single-use accessories, consumables, and general maternal monitors sit outside this estimate.

Segmentation Overview

  • Fetal Dopplers
    • Fetal Magnetic Resonance Imaging (MRI) Devices
      • Ultrasound Devices
      • Fetal Pulse Oximeters
      • Other Fetal Care Equipment
    • Neonatal Care Equipment
      • Incubators
      • Neonatal Monitoring Devices
      • Phototherapy Equipment
      • Respiratory Assistance & Monitoring Devices
      • Other Neonatal Care Equipment
  • By End-user
    • Hospitals
    • Maternity Clinics & Birthing Centers
    • Home-Care Settings
  • By Modality
    • Stand-alone Devices
    • Portable/Hand-held Devices
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Detailed Research Methodology and Data Validation

Primary Research

Mordor analysts held structured calls with neonatologists, biomedical engineers, perinatal nurses, and procurement leads across North America, Europe, India, and Brazil. These talks validated device utilization, replacement cycles, and price dispersion, letting us fine-tune insights from desk work.

Desk Research

We began by mining national birth registries, WHO and UNICEF preterm files, CDC and Eurostat live-birth data, and UN population projections to anchor cohort volumes. Trade logs such as MedTech Europe, alongside customs HS-code exports, traced device flows into key markets.

Public 10-Ks, investor decks, and MEDDEV filings clarified average selling prices, while D&B Hoovers and Dow Jones Factiva provided private-firm breadcrumbs. Patent scans on Questel revealed emerging portable monitors. This list is illustrative, not exhaustive, and many additional sources informed checks.

Market-Sizing & Forecasting

Our model starts with a top-down live-birth pool multiplied by preterm incidence and NICU penetration, then values demand with region-weighted ASP curves. Supplier roll-ups, channel checks, and sampled ASP × volume calculations offer selective bottom-up corroboration before totals lock. Key drivers, NICU bed density, smart-monitor approvals, hospital capital spend per birth, replacement cycle length, and insurer reimbursement moves feed a multivariate regression, with scenario analysis absorbing policy or currency shocks.

Data Validation & Update Cycle

Outputs pass variance scans against import duties, public tenders, and listed segment sales. Two analysts review anomalies, and reports refresh yearly, with interim updates for major recalls or guideline shifts to keep clients current.

Why Mordor's Fetal and Neonatal Care Equipment Baseline Remains Highly Trusted

Published estimates often diverge because firms bucket devices differently, apply flat ASPs, or refresh at irregular intervals.

Our disciplined scope, verified birth statistics, and annually reviewed currency tables give decision-makers steadier footing.

Benchmark comparison

Market Size Anonymized source Primary gap driver
USD 9.68 B (2025) Mordor Intelligence -
USD 9.50 B (2024) Global Consultancy A Counts disposables and NICU renovation spend
USD 8.20 B (2024) Industry Association B Omits fetal imaging, uses uniform ASPs

These contrasts show why our numbers stay balanced, transparent, and traceable to concrete variables clients can replay with ease.

Key Questions Answered in the Report

How big is the Global Fetal and Neonatal Care Equipment Market?

The Global Fetal and Neonatal Care Equipment Market size is expected to reach USD 8.36 billion in 2025 and grow at a CAGR of 6.57% to reach USD 11.48 billion by 2030.

1. What is the current size of the fetal and neonatal care equipment market?

The market reached USD 9.68 billion in 2025 and is projected to climb to USD 13.15 billion by 2030, reflecting a 6.31% CAGR.

2. Which segment is growing fastest in the fetal and neonatal care equipment market?

AI-enabled fetal monitoring devices are expanding at an 8.02% CAGR to 2030, outpacing neonatal equipment sales.

3. Why are portable and hand-held devices gaining traction?

Wireless connectivity, maternal mobility benefits, and easier home-care integration drive an 8.75% CAGR for portable systems.

4. How are regulatory changes influencing market growth?

New FDA cybersecurity and quality-system rules add cost and time to approvals, trimming the forecast CAGR by an estimated 1.1 percentage points.

5. What role does AI play in neonatal and fetal care equipment?

AI algorithms enable predictive analytics for cardiac assessment, nutrition dosing, and jaundice forecasting, improving outcomes and unlocking new revenue.

6. Which region offers the highest growth potential?

Asia Pacific leads with a 9.01% CAGR, fueled by government investments and rapid adoption of AI-based diagnostic tools.

Page last updated on:

Fetal And Neonatal Care Equipment Report Snapshots